Concerns about anti-angiogenic treatment in patients with glioblastoma multiforme
<p>Abstract</p> <p>Background</p> <p>The relevance of angiogenesis inhibition in the treatment of glioblastoma multiforme (GBM) should be considered in the unique context of malignant brain tumours. Although patients benefit greatly from reduced cerebral oedema and intr...
Main Authors: | Richel Dirk J, van Linde Myra E, Stalpers Lukas JA, Claes An, van Tellingen Olaf, Verhoeff Joost JC, Leenders William PJ, van Furth Wouter R |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2009-12-01
|
Series: | BMC Cancer |
Online Access: | http://www.biomedcentral.com/1471-2407/9/444 |
Similar Items
-
The complement system in glioblastoma multiforme
by: T. A. M. Bouwens van der Vlis, et al.
Published: (2018-09-01) -
Glioblastoma multiforme has many faces
by: Philip Huxham Jansen van Rensburg, et al.
Published: (2012-09-01) -
Glioblastoma multiforme
by: Melissa Serra Ruíz, et al.
Published: (2019-04-01) -
Glioblastoma Multiforme
by: Jonas M. Sheehan, et al.
Published: (2012-01-01) -
Glioblastoma multiforme
by: Melissa Serra Ruíz, et al.
Published: (2019-04-01)